Allin et al. followed up with 10,408 individuals from the Danish general population for up to 16 years and found a 2- (HR: 2.2; 95% CI: 1.0–4.6) and 1.3-fold (HR: 1.3; 95% CI: 1.0–1.6) increased risk of lung cancer and cancer of any type in those in the highest vs. the lowest quartile of CRP concentrations [31]. This evidence concerns the gene CRP and lung cancer.